Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Chubb
Accenture
UBS
US Army
Cantor Fitzgerald
Cerilliant
AstraZeneca
Merck

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022020

« Back to Dashboard

NDA 022020 describes PROTONIX, which is a drug marketed by Wyeth Pharms Inc and is included in three NDAs. It is available from four suppliers. There are seven patents protecting this drug and one Paragraph IV challenge. Additional details are available on the PROTONIX profile page.

The generic ingredient in PROTONIX is pantoprazole sodium. There are forty-eight drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the pantoprazole sodium profile page.
Summary for 022020
Tradename:PROTONIX
Applicant:Wyeth Pharms Inc
Ingredient:pantoprazole sodium
Patents:4
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 022020
Mechanism of ActionProton Pump Inhibitors
Suppliers and Packaging for NDA: 022020
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROTONIX pantoprazole sodium FOR SUSPENSION, DELAYED RELEASE;ORAL 022020 NDA Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. 0008-0844 N 0008-0844-02
PROTONIX pantoprazole sodium FOR SUSPENSION, DELAYED RELEASE;ORAL 022020 NDA Cardinal Health 55154-4232 N 55154-4232-0

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION, DELAYED RELEASE;ORALStrengthEQ 40MG BASE
Approval Date:Nov 14, 2007TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Dec 7, 2026Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Sign UpPatent Expiration:Mar 30, 2025Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Sign UpPatent Expiration:Mar 30, 2025Product Flag?Substance Flag?Delist Request?Y

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
US Army
Cipla
Medtronic
Deloitte
Daiichi Sankyo
AstraZeneca
Chinese Patent Office
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.